stock trading simulator


Succeeding 13 years of R&D with a commercial-level rare disease drug, Sarepta Therapeutics, Inc. (NASDAQ:SRPT) tees up to deliver on the latter half of its promise to provide the world with a DMD cure for sufferers that may be amenable to Exon 51 skipping, and otherwise. A result that would facilitate the first cure for DMD and sizable growth potential.

In 2016, Sarepta Therapeutics, a biopharmaceutical company focused on developing unique RNA-targeted therapeutics (for the treatment of rare neuromuscular diseases), saw its Exondys 51 (eteplirsen), a drug for specific Duchenne Muscular Dystrophy (DMD) sufferers, enter what was a highly contentious phase 3 clinical trial review by the FDA, which triggered industry-wide controversy.


Duchenne muscular dystrophy, the most common fatal genetic disorder diagnosed in childhood (300,000 current suffers worldwide (Duchenne UK)), is caused by a dystrophin deficiency, attributed to defective genes (not all sufferer s have a genetic predisposition to this, however). Men and Women have an equal chance of carrying the defective gene, but most (98%+) sufferers are male (mda.org). Similar to other muscular dystrophies, DMD deteriorates progressively, vigorously, debilitating its suffers. Symptoms most often appear before age 6, and they consist of (but are not limited to) fatigue, intellectual disability, cardiomyopathy, arrhythmia, scoliosis, biological wasting, respiratory disorders, muscle deformities, random muscle contraction and principally, the weakening of muscles (beginning and spreading from the legs and pelvis), a process that develops exponentially and leads to complications with motor skills. Eventually, DMD completely immobilizes sufferers- the life expectancy of whom is estimated to be around 25 years old (MuscularDystrophy UK).

stock trading simulator: Technology Select Sector SPDR ETF (XLK)


Advisors’ Opinion:

  • [By Money Morning News Team]

    If the price is keeping you out of GOOGL, take a look at theTechnology SPDR ETF (NYSE Arca: XLK), where you get to hold shares of many of these top tech companies at a fraction of the cost.

  • [By Tom Gentile]

    Both XLV and the Technology Select Sector SPDR ETF (NYSE Arca: XLK) are the two top-performing sectors so far this year, and both have performed better than the next-best ETF by at least a full 5% or more.

stock trading simulator: Myriad Genetics, Inc.(MYGN)


Advisors’ Opinion:

  • [By Cory Renauer]

    Shares of Myriad Genetics, Inc. (NASDAQ:MYGN), a DNA diagnostics specialist, dropped 61.4% last year, according todata from S&P Global Market Intelligence.Efforts to offset hereditary cancer-testing segment losses just weren’t successful enough to keep profits, and the stock, from sliding last year.

stock trading simulator: Immunomedics, Inc.(IMMU)


Advisors’ Opinion:

  • [By Chris Lange]

    Immunomedics, Inc. (NASDAQ: IMMU) saw its shares rise after the firm sent out a letter to shareholders imploring them to vote for its director nominees at the upcoming annual stockholders meeting on February 16. The board of directors is making this request because it is currently waging a proxy contest with venBio SelectAdvisor.

stock trading simulator: DRDGOLD Limited(DRD)


Advisors’ Opinion:

  • [By Alex McGuire]

    This list ranks gold dividend stocks in the mining sector by dividend yield. And it also includes one of our top gold stock recommendations of 2017…

    Gold Dividend Stock Share Price Year-to-Date Performance Dividend Yield (as of June 30) DRDGOLD Ltd. (NYSE ADR: DRD) $3.19 -39.7% 10.24% Sibanye Gold Ltd. (NYSE ADR: SBGL) $4.70 -33.4% 5.98% Harmony Gold Mining Co. (NYSE ADR: HMY) $1.62 -26.7% 4.56% Gold Fields Limited (NYSE ADR: GFI) $3.41 +13.3% 2.73% Randgold Resources Ltd. (Nasdaq ADR: GOLD) $87.68 +14.9% 1.89% Franco Nevada Corp. (NYSE: FNV) $72.39 +21.1% 1.27% Royal Gold Inc. (Nasdaq: RGLD) $76.85 +21.3% 1.25% Eldorado Gold Corp. (NYSE: EGO) $2.58 -19.9% 1.16% Barrick Gold Corp. (NYSE: ABX) $15.90 -0.5% 0.75% Goldcorp Inc. (NYSE: GG) $13.02 -4.4% 0.62%


    Six of the 10 gold stocks listed above have posted negative returns so far in 2017. The main reason behind their losses has to do with gold price volatility.

  • [By Lisa Levin]

    In trading on Wednesday, basic materials shares fell by 1.27 percent. Meanwhile, top losers in the sector included McEwen Mining Inc (NYSE: MUX), down 12 percent, and DRDGOLD Ltd. (ADR) (NYSE: DRD), down 7 percent.

  • [By Lisa Levin]

    Tuesday afternoon, the basic materials sector proved to be a source of strength for the market. Leading the sector was strength from Endeavour Silver Corp (NYSE: EXK) and DRDGOLD Ltd. (ADR) (NYSE: DRD).

stock trading simulator: CoreSite Realty Corporation(COR)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Denver, Colorado-based CoreSite Realty Corporation (COR) offers cloud-enabled, high-performance data center campuses.

    Operating across 17 data centers in eight key North American markets, CoreSite serves a broad range of clients, including telecommunications carriers, media companies, financial and educational institutions, and government agencies.

Leave a Reply

Your email address will not be published. Required fields are marked *